NOVARTIS AG
NVS · CIK 0001114448 · Pharmaceutical Preparations
About NOVARTIS AG
Novartis AG, our Swiss holding company, owns, directly or indirectly, all of our significant operating companies. For a list of our significant operating subsidiaries, see “Item 18.
Business information sourced from SEC annual filing filed Feb 4, 2026. Business descriptions reflect the cited filing and may not describe subsequent changes.
Company identification is based on SEC registration information. Financial figures are sourced from SEC filings.
Financial highlights
Latest qualifying annual SEC observations · USDHistorical financial performance
USD billions · Annual SEC observations · Choose a metric
Each metric uses a consistent SEC accounting concept when available. Fiscal year-end dates may differ across metrics. Negative values are displayed with a minus sign.
Annual financial history
USD · Exact fiscal period ends| Period ended | Revenue | Net income | Operating income | Assets | Liabilities | Cash | Operating cash flow | Net margin |
|---|---|---|---|---|---|---|---|---|
| No qualifying annual financial data available. | ||||||||
A dash indicates unavailable or nonmatching period data. Figures are SEC observations, not estimates.
Company information
- Registered name
- NOVARTIS AG
- Ticker symbol
- NVS
- CIK
- 0001114448
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC SIC code
- 2834
- Fiscal year end (MMDD)
- 1231
- Last SEC synchronization
- Nov 7, 2026 15:38 UTC
- Headquarters / business address
- LICHTSTRASSE 35
BASEL, V8 CH 4056 - Mailing address
- LICHTSTRASSE 35
BASEL, V8 CH 4056 - Business phone
- 01141613241111
Company contact information is drawn from SEC submissions, where reported, and may not reflect current operating locations. Last company information check: Nov 7, 2026 20:22 UTC. Official website, business descriptions and executive details require separate verification.
Latest SEC filings
Browse filings →| Form | Filed | Report period | Official source |
|---|---|---|---|
| 4 | July 16, 2020 | July 14, 2020 | View SEC filing ↗ |
| 4 | July 2, 2020 | June 30, 2020 | View SEC filing ↗ |
| 4 | June 22, 2020 | June 18, 2020 | View SEC filing ↗ |
| 4 | June 17, 2020 | June 15, 2020 | View SEC filing ↗ |
| 4 | June 12, 2020 | June 10, 2020 | View SEC filing ↗ |
| 4 | June 9, 2020 | June 5, 2020 | View SEC filing ↗ |
| 4 | June 4, 2020 | June 2, 2020 | View SEC filing ↗ |
| 4 | Nov. 12, 2019 | Nov. 12, 2019 | View SEC filing ↗ |
| 4 | May 30, 2019 | May 28, 2019 | View SEC filing ↗ |
| 4 | April 29, 2019 | April 25, 2019 | View SEC filing ↗ |
| 4 | April 24, 2019 | April 22, 2019 | View SEC filing ↗ |
| 4 | April 15, 2019 | April 11, 2019 | View SEC filing ↗ |
| 4 | April 10, 2019 | April 8, 2019 | View SEC filing ↗ |
| 4 | April 5, 2019 | April 3, 2019 | View SEC filing ↗ |
| 4 | April 2, 2019 | March 29, 2019 | View SEC filing ↗ |
| 4 | April 2, 2019 | March 29, 2019 | View SEC filing ↗ |
| 4 | March 28, 2019 | March 26, 2019 | View SEC filing ↗ |
| 4 | March 15, 2019 | March 13, 2019 | View SEC filing ↗ |
| 4 | Oct. 4, 2018 | Oct. 2, 2018 | View SEC filing ↗ |
| 4 | Sept. 14, 2018 | Sept. 12, 2018 | View SEC filing ↗ |
Financial data is provided for informational purposes, not investment advice. Observations may include restatements; review original SEC filings before making decisions.